BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2023-12

297 industry Phase 2/3 trial readout(s) and 28 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2023-11 | 2024-01 →

FDA decision events

DateEventStatusCompanyDrugSource
2023-12-01FDA approvalapprovedLOXO ONCOLJAYPIRCAApproved 2023-12-01: JAYPIRCA (NDA216059 SUPPL1)
2023-12-01FDA approvalapprovedASTRAZENECA AB AZNSAPHNELOApproved 2023-12-01: SAPHNELO (BLA761123 SUPPL3)
2023-12-05FDA approvalapprovedNOVARTIS NVSFABHALTAApproved 2023-12-05: FABHALTA (NDA218276 ORIG1)
2023-12-05FDA approvalapprovedHANDA THERAPPHYRAGOApproved 2023-12-05: PHYRAGO (NDA216099 ORIG1)
2023-12-06FDA approvalapprovedBIO-THERA SOLUTIONS LTDAVZIVIApproved 2023-12-06: AVZIVI (BLA761198 ORIG1)
2023-12-08FDA approvalapprovedASTELLASCRESEMBAApproved 2023-12-08: CRESEMBA (NDA207500 SUPPL15)
2023-12-08FDA approvalapprovedASTELLASCRESEMBAApproved 2023-12-08: CRESEMBA (NDA207501 SUPPL13)
2023-12-11FDA approvalapprovedPharmaand GmbHPEGASYSApproved 2023-12-11: PEGASYS (BLA103964 SUPPL5276)
2023-12-13FDA approvalapprovedUSWMIWILFINApproved 2023-12-13: IWILFIN (NDA215500 ORIG1)
2023-12-13FDA approvalapprovedGLAUKOS GKOSIDOSE TRApproved 2023-12-13: IDOSE TR (NDA218010 ORIG1)
2023-12-14FDA approvalapprovedHIKMAHYDROMORPHONE HYDROCHLORIDEApproved 2023-12-14: HYDROMORPHONE HYDROCHLORIDE (NDA217812 ORIG1)
2023-12-14FDA approvalapprovedLEO PHARMA ASADBRYApproved 2023-12-14: ADBRY (BLA761180 SUPPL1)
2023-12-14FDA approvalapprovedMERCK SHARP DOHME MRKWELIREGApproved 2023-12-14: WELIREG (NDA215383 SUPPL6)
2023-12-14FDA approvalapprovedPFIZER PFECIBINQOApproved 2023-12-14: CIBINQO (NDA213871 SUPPL4)
2023-12-15Complete response letterapproved sinceCheckpoint Therapeutics, Incorporatedcosibelimab (CK- 301)CRL 2023-12-15: Checkpoint Therapeutics, Incorporated BLA 761297 (cosibelimab (CK- 301))
2023-12-15FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2023-12-15: KEYTRUDA (BLA125514 SUPPL151)
2023-12-15FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2023-12-15: KEYTRUDA (BLA125514 SUPPL152)
2023-12-15FDA approvalapprovedARCUTIS ARQTZORYVEApproved 2023-12-15: ZORYVE (NDA217242 ORIG1)
2023-12-15FDA approvalapprovedASTELLASPADCEVApproved 2023-12-15: PADCEV (BLA761137 SUPPL24)
2023-12-15FDA approvalapprovedASTELLASPADCEVApproved 2023-12-15: PADCEV (BLA761137 SUPPL25)
2023-12-18Complete response letterapproved sinceCooperSurgical, Inc.Paragard (intrauterine copper contraceptive)CRL 2023-12-18: CooperSurgical, Inc. NDA 018680/S-074 (Paragard (intrauterine copper contraceptive))
2023-12-18FDA approvalapprovedCHIESIFILSUVEZApproved 2023-12-18: FILSUVEZ (NDA215064 ORIG1)
2023-12-19FDA approvalapprovedJANSSEN BIOTECHERLEADAApproved 2023-12-19: ERLEADA (NDA210951 SUPPL14)
2023-12-20FDA approvalapprovedCALLIDITASTARPEYOApproved 2023-12-20: TARPEYO (NDA215935 SUPPL3)
2023-12-21FDA approvalapprovedBEONE MEDICINES USA ONCBRUKINSAApproved 2023-12-21: BRUKINSA (NDA213217 SUPPL9)
2023-12-21FDA approvalapprovedASTRAZENECA AB AZNWAINUAApproved 2023-12-21: WAINUA; WAINUA (AUTOINJECTOR) (NDA217388 ORIG1)
2023-12-22FDA approvalapprovedPHARMOBEDIENTABACAVIR SULFATE AND LAMIVUDINEApproved 2023-12-22: ABACAVIR SULFATE AND LAMIVUDINE (NDA204311 ORIG1)
2023-12-22FDA approvalapprovedCOHERUS BIOSCIENCES INC CHRSUDENYCAApproved 2023-12-22: UDENYCA (BLA761039 SUPPL15)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2023-12 est.P2Longeveron Inc. LGVNNCT02587572 Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA TrialMetabolic Disease; Endothelial Dysfunctionwithdrawn
2023-12P2Prokidney PROKNCT02836574 A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney DiseaseType 2 Diabetes Mellitus; Chronic Kidney Diseasecompleted83
2023-12 est.P3Ablative Solutions, Inc.NCT02910414 TARGET BP I Clinical TrialHypertensionactive not recruiting300
2023-12 est.P1/P2Healeon Medical IncNCT02987855 Adipose Stem/Stromal Cells in RSD, CRPS, FibromyalgiaRSD (Reflex Sympathetic Dystrophy); CRPS - Complex Regional Pain Syndrome Type I; Fibromyalgiawithdrawn
2023-12 est.P3Nutricia ResearchNCT03062995 A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in InfanImmunitywithdrawn
2023-12 est.P2Infan Industria Quimica Farmaceutica NacionalNCT03084952 Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis PatientsLeishmaniasis; American, Cutaneous; Drug Side Effectunknown52
2023-12 est.P2Zydus Therapeutics Inc.NCT03097107 Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dLDyslipidemiassuspended124
2023-12 est.P3Sequential Medicine LtdNCT03338764 An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient InsomniaTransient Insomniawithdrawn
2023-12 est.P3Symphogen A/SNCT03717038 Sym004 Versus TAS-102 in Patients With mCRCMetastatic Colorectal Cancer; Colorectal Cancer Metastatic; Carcinomawithdrawn
2023-12 est.P3BiocadNCT03912389 Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLCNon-Squamous Non-Small Cell Neoplasm of Lungunknown292
2023-12 est.P1/P2Actinium Pharmaceuticals ATNMNCT03932318 Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML PatientsAcute Myeloid Leukemia; Relapsed Adult AMLwithdrawn
2023-12 est.P2GeneOne Life Science, Inc.NCT04060316 GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus SurgerySinusitis Chronicunknown99
2023-12 est.P3Applied Therapeutics, Inc. AMATNCT04083339 Safety and Efficacy of AT-001 in Patients With Diabetic CardiomyopathyDiabetic Cardiomyopathiesactive not recruiting675
2023-12 est.P2VistaGen Therapeutics, Inc. VTGNNCT04147949 AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced DyskinesiaParkinson Disease; Dyskinesia, Medication-Induced; L-Dopa Causing Adverse Effects in Therapeutic Useunknown20
2023-12 est.P3Infectopharm Arzneimittel GmbHNCT04398758 Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early ChildhoodAtopic Dermatitis; Infant, Newbornunknown360
2023-12 est.P3Asieris MediTech (Hong Kong) Co., Ltd.NCT04484415 Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)Cervical Intraepithelial Neoplasia Grade 2/3unknown402
2023-12 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04503902 Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinomaunknown46
2023-12 est.P2AB ScienceNCT04622865 Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19SARS-CoV 2; COVID-19; Coronavirus Disease 2019unknown200
2023-12 est.P3Hamad Medical CorporationNCT04654507 Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in ChildrenUrinary Tract Infections in Children; Dexamethasone; Kidney Scarring; Acute Pyelonephritis; Hypertenunknown120
2023-12 est.P1/P2ASC TherapeuticsNCT04676048 ASC618 Gene Therapy in Hemophilia A PatientsHemophilia Arecruiting12
2023-12 est.P2ES Therapeutics Australia Pty LtdNCT04714996 Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant EpilepsyDrug Resistant Epilepsyunknown24
2023-12 est.P2Biosolution Co., Ltd.NCT04744402 Phase 2 Clinical Trial of CartiLife® in the United StatesArticular Cartilage Defect; Articular Cartilage Degenerationrecruiting25
2023-12 est.P1/P2Elpiscience Biopharma, Ltd.NCT04841538 A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic TumorsThoracic Tumors; Non-small Cell Lung Cancer; Small Cell Lung Cancerwithdrawn
2023-12 est.P2/P3ProQR Therapeutics PRQRNCT04855045 An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) WiLeber Congenital Amaurosis 10; Blindness; Leber Congenital Amaurosis; Vision Disorders; Sensation Diunknown15
2023-12 est.P2Emerald Health PharmaceuticalsNCT04909502 Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple SclerosisRelapsing Forms of Multiple Sclerosissuspended50
2023-12 est.P2Phoenicis TherapeuticsNCT05020730 Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis SuppurativaHidradenitis Suppurativaunknown50
2023-12 est.P2EMSNCT05031481 Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.Vulvovaginal Candidiasiswithdrawn
2023-12 est.P2AB ScienceNCT05047783 Masitinib in Patients With Symptomatic Mild to Moderate COVID-19Covid19; SARS-CoV2 Infection; Coronavirus Disease 2019unknown78
2023-12 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT05054842 Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 DiabetesType 2 Diabetesunknown174
2023-12 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05068206 A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeUnresectable Metastatic Colorectal Cancerunknown120
2023-12 est.P1/P2National Vaccine and Serum Institute, ChinaNCT05069129 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population AgeCOVID-19 Pneumonia; Coronavirus Infectionsunknown1848
2023-12 est.P2Shanghai Miracogen Inc.NCT05141747 A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.Locally Advanced Gastric Cancer; Metastatic HER2 Positive Gastroesophageal Junction Cancerunknown60
2023-12 est.P2Shanghai Miracogen Inc.NCT05141786 A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC).Non-small- Cell Lung Cancer (NSCLC)unknown100
2023-12 est.P1/P2ChitogenX IncNCT05333211 Ortho-R® for Rotator Cuff Repair Compared With Standard of Care Rotator Cuff Repair Without Ortho-R®Rotator Cuff Tearsunknown78
2023-12 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05346952 A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the TreatmenAdvanced Non-squamous Non-small Cell Lung Cancerunknown390
2023-12 est.P2/P3Yantai Patronus Biotech Co., Ltd.NCT05602558 The Phase Ⅱ/Ⅲ Trial of LYB001COVID-19unknown18000
2023-12 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05645315 Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid TumorsAdvanced Solid Tumorunknown127
2023-12 est.P2Bioxytran Inc. BIXTNCT05733780 To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-MCOVID-19; SARS CoV 2 Infectionunknown40
2023-12 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05775575 A Clinical Trial of TQB3909 Tablets in Patients With Breast CancerAdvanced Breast Cancerunknown65
2023-12 est.P2Innovo Therapeutics, Inc.NCT05838833 Ointment to Prevent Scar After ThyroidectomyScarunknown75
2023-12 est.P2Beijing Tide Pharmaceutical Co., LtdNCT05950152 Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal SurgeryPain, Post-operativeunknown108
2023-12 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT06047483 A Trial of HRF2105 Patch in Relieving Pain of OsteoarthritisAnalgesia and Anti-inflammatory of Osteoarthritisunknown90
2023-12-01P2CUTISS AGNCT03394612 Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and ChildrenSkin Woundcompleted21
2023-12-01 est.P2Jubilant DraxImage Inc.NCT03561259 A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma SubjectsNeuroblastoma; Neuroectodermal Tumors; Neoplasmsunknown60
2023-12-01 est.P3Anji PharmaNCT04854512 Investigational Study of Delayed Release MetforminDiabetes Mellitus, Type 2suspended675
2023-12-01 est.P1/P2Beijing Immunochina Medical Science & Technology Co., Ltd.NCT05117138 Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced TumorsMelanoma; Non-small Cell Lung Cancer; Head and Neck Squamous Cell Carcinomaunknown39
2023-12-04P3Cerus Corporation CERSNCT03459287 Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery PatientsAnemiacompleted581
2023-12-04 est.P2ViGenCell Inc.NCT03671850 VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma PatientsExtranodal NK/T-cell Lymphomaunknown48
2023-12-04P2Beijing Continent Pharmaceutical Co, Ltd.NCT03902509 A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.Radiation-induced Lung Injurycompleted126
2023-12-04P2Janssen Research & Development, LLCNCT04083976 A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene AlterationsAdvanced Solid Tumorcompleted316
2023-12-04P2Aribio Lab Co., Ltd.NCT04289987 A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B VaccineHepatitis B, Chroniccompleted134
2023-12-04P2Genentech, Inc.NCT04632992 A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of RespoAdvanced Unresectable or Metastatic Solid Malignancycompleted252
2023-12-04P3Annovis Bio Inc. ANVSNCT05357989 A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDParkinson's Disease, Idiopathiccompleted523
2023-12-04P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05475717 A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKIContrast-induced Acute Kidney Injuryterminated132
2023-12-04P2Larimar Therapeutics, Inc. LRMRNCT05579691 A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's AtaxiaFriedreich Ataxiacompleted28
2023-12-04P3Keymed Biosciences Co.LtdNCT05908032 Study of CM310 in Subjects With Allergic RhinitisAllergic Rhinitiscompleted108
2023-12-04P3Daewon Pharmaceutical Co., Ltd.NCT07076056 Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2Type 2 Diabetescompleted230
2023-12-05P1/P2Spark Therapeutics, Inc. SPKLFNCT03003533 A Gene Transfer Study for Hemophilia AHemophilia Acompleted25
2023-12-05P1/P2Nanjing Leads Biolabs Co.,LtdNCT05107011 Phase I/II Clinical Trial of LBL-015 for InjectionAdvanced Malignant Tumorcompleted25
2023-12-05P2Jazz Pharmaceuticals JAZZNCT05178316 A Study of JZP150 in Adults With Posttraumatic Stress DisorderPost Traumatic Stress Disordercompleted282
2023-12-05P2Daewoong Pharmaceutical Co. LTD.NCT05378360 DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin ToxicitiesRash Acneiformcompleted96
2023-12-05P3Taisho Pharmaceutical Co., Ltd.NCT05453136 Phase III Study of TS-142 in Patients with InsomniaPatients with Insomniacompleted1155
2023-12-05P2Beijing Suncadia Pharmaceuticals Co., LtdNCT05690711 A Trial of HRS8179 on Brain Swelling After Large Hemispheric InfarctionBrain Swelling, Large Hemispheric Infarctioncompleted40
2023-12-05 est.P1/P2Pure Green Pharmaceuticals Inc. PURENCT05766969 Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEADiabetic Peripheral Neuropathic Painunknown52
2023-12-05P2Shandong New Time Pharmaceutical Co., LTDNCT06226350 A Phase Ⅱ Study of F520 in Patients With Cervical CarcinomaCervical Cancercompleted29
2023-12-06P1/P2NantPharma, LLCNCT03127124 QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic CancerPancreatic Adenocarcinoma Metastaticwithdrawn
2023-12-06P3Millennium Pharmaceuticals, Inc. MGIHNCT03748953 Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell TransplantatioMultiple Myelomacompleted37
2023-12-06P1/P2Aposcience AGNCT04277598 A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot UlcerDiabetic Foot Ulcer (DFU)completed159
2023-12-06P1/P2Entos Pharmaceuticals Inc.NCT04591184 A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in AdultsSARS-CoV-2completed268
2023-12-06P2Bristol-Myers Squibb BMYNCT05169684 A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerProstatic Neoplasms, Castration-Resistantterminated10
2023-12-06P2BioLite, Inc.NCT05202327 PDC-1421 Treatment in Adult Patients With ADHDAttention-Deficit Hyperactivity Disorder (ADHD)completed99
2023-12-06P2Aclaris Therapeutics, Inc. ACRSNCT05511519 Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic ArthritisPsoriatic Arthritisterminated47
2023-12-06P2Janssen Research & Development, LLCNCT05564052 A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell LymphomaLymphoma, Mantle-Cellcompleted36
2023-12-06P3GlaxoSmithKlineNCT05879107 Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) IRespiratory Syncytial Virus Infectionscompleted1113
2023-12-06P2Zhejiang Echon Biopharm LimitedNCT06429566 Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous UlcersHealthyunknown120
2023-12-07P1/P2BeiGeneNCT04276493 Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without TislelizumabBreast Cancer; Gastric Cancer; Gastroesophageal Junction Cancercompleted71
2023-12-07P2Pfizer PFENCT04996004 A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaLeiomyosarcomaterminated76
2023-12-07P2Dreamhawk Vision Biotech, Inc.NCT05486728 Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseaseDry Eye Diseasecompleted85
2023-12-08P2Palatin Technologies, Inc PTNNCT04318145 Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure SubjectsHeart Failure With Preserved Ejection Fractionterminated15
2023-12-08P2Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyNCT04764448 A Study of Belcesiran in Patients With AATLDAlpha 1-Antitrypsin Deficiencyterminated16
2023-12-08P3Jiangsu Simcere Pharmaceutical Co., Ltd.NCT04908787 A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian CancerOvarian Cancercompleted421
2023-12-08P3Novartis Pharmaceuticals NVSNCT05048342 A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistaminesChronic Spontaneous Urticariacompleted71
2023-12-08P2Novartis Pharmaceuticals NVSNCT05114746 Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in JapanProstate Cancercompleted94
2023-12-10P2Taiwan Bio Therapeutics Inc.NCT05027581 Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)Osteoarthritis, Kneecompleted72
2023-12-10P2Keymed Biosciences Co.LtdNCT05908721 Study of CM310 in Patients With Allergic RhinitisAllergic Rhinitiscompleted100
2023-12-10 est.P2Sinocelltech Ltd.NCT05933512 A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster VaccinesCOVID-19; SARS-CoV-2 Infectionunknown600
2023-12-11P3Novartis Pharmaceuticals NVSNCT03439046 Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With aBreast Cancerterminated287
2023-12-11P2Kadmon, a Sanofi CompanyNCT03640481 Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyChronic Graft-versus-host-diseaseterminated159
2023-12-11P2Eli Lilly and Company LLYNCT04166773 A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Steatohepatitiscompleted190
2023-12-11P1/P2PrecirixNCT04467515 A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Proterminated13
2023-12-11P3Sylentis, S.A.NCT04819269 Tivanisiran for Dry Eye in Subjects With Sjögren's SyndromeDry Eye Disease; Sjögren Syndromecompleted203
2023-12-11P2Alnylam Pharmaceuticals ALNYNCT05103332 Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)Hypertensioncompleted663
2023-12-11P3Hanmi Pharmaceutical Company Limited HAFCNCT05450601 A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension PatientsHypertensioncompleted249
2023-12-11P2Staidson (Beijing) Biopharmaceuticals Co., LtdNCT05760703 Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis BChronic Hepatitis bterminated9
2023-12-11P2Staidson (Beijing) Biopharmaceuticals Co., LtdNCT05760781 To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis BChronic Hepatitis bterminated9
2023-12-11P3CanSino Biologics Inc.NCT06011200 A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old PopulationEpidemic Meningitiscompleted1000
2023-12-12P2Changchun GeneScience Pharmaceutical Co., Ltd.NCT02375620 Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short StatureShort Stature Children Born Small for Gestational Age (SGA)active not recruiting96
2023-12-12P1/P2HUYABIO International, LLC.NCT02718066 Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung CancerMelanoma; Renal Cell Carcinoma; Non-Small Cell Lung Cancercompleted96
2023-12-12P3Bristol-Myers Squibb BMYNCT04340193 A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage LiveCancer, Hepatocellularcompleted26
2023-12-12P3Ferring PharmaceuticalsNCT04773353 Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian WomenInfertilitycompleted220
2023-12-12P3Merck Sharp & Dohme LLC MRKNCT05119855 Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory SPapillomavirus Infections; Coronavirus Disease (COVID-19)completed165
2023-12-12P2Janssen Research & Development, LLCNCT05275023 An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in ChHepatitis B, Chroniccompleted37
2023-12-12P3Vertex Pharmaceuticals Incorporated VERXNCT05661734 A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute PainPaincompleted258
2023-12-13P3ShireNCT03283085 A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)Crohn's Disease; Ulcerative Colitiscompleted557
2023-12-13P3Jiangsu HengRui Medicine Co., Ltd.NCT04956432 A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With GoutGoutcompleted779
2023-12-13P2Regeneron Pharmaceuticals REGNNCT05088460 A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)Familial Partial Lipodystrophy; Metabolic Abnormalitiesterminated20
2023-12-13P3Novo Nordisk A/S NVONCT05259033 A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in PeopleDiabetes Mellitus, Type 2completed683
2023-12-13P2EmpowerPharm Inc.NCT05600114 Cannabidiol (CBD) for the Treatment of Social Anxiety DisorderSocial Anxiety Disordercompleted239
2023-12-13P2Takeda TAKNCT05687916 A Study of TAK-861 in Participants With Narcolepsy Type 2Narcolepsy Type 2completed71
2023-12-14P2MAPS Europe B.V.NCT04030169 Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-StudyPTSDcompleted21
2023-12-14P2HI-Bio, A Biogen CompanyNCT04733040 Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)Glomerulonephritis; Membranous Nephropathy; antiPLA2R Positivecompleted24
2023-12-14 est.P2BioSight Ltd.NCT04749355 Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDSAML, Adult; MDS; Relapse/Recurrence; Refractory Acute Myeloid Leukemiaunknown40
2023-12-14P2Merck Sharp & Dohme LLC MRKNCT04875195 A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell LymHodgkin's Lymphoma; Primary Mediastinal Large B-cell Lymphoma (PMBCL)completed66
2023-12-14P2/P3Reneo Pharma LtdNCT05267574 An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead)Primary Mitochondrial Myopathyterminated155
2023-12-14P3mAbxience Research S.L.NCT05338086 A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.Postmenopausal Women With Osteoporosiscompleted558
2023-12-14P3Biopharma Plasma LLCNCT05422365 Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in AdultsPrimary Immune Thrombocytopeniacompleted32
2023-12-14P2Takeda TAKNCT05687903 A Study of TAK-861 in Participants With Narcolepsy Type 1Narcolepsy Type 1completed112
2023-12-14P2Suzhou Kintor Pharmaceutical Inc,NCT06692465 To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult MalesAlopecia; Male Pattern Hair Losscompleted180
2023-12-15P2CelgeneNCT03484702 Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin LymphomaLymphoma, Non-Hodgkincompleted113
2023-12-15P1/P2TJ Biopharma Co., Ltd.NCT04202003 A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes(MDS)completed105
2023-12-15P3Incyte Corporation INCYNCT04205812 Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung CancerMetastatic Squamous Non-Small Cell Lung Cancer; Metastatic Nonsquamous Non-Small Cell Lung Cancercompleted583
2023-12-15 est.P2/P3Biomed Industries, Inc.NCT04452565 NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 InfectionCoronavirus Infection; Severe Acute Respiratory Infection; Severe Acute Respiratory Syndrome Coronavunknown525
2023-12-15P2Akero Therapeutics, IncNCT05039450 A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)NASH - Nonalcoholic Steatohepatitiscompleted213
2023-12-15 est.P2Shanghai Henlius BiotechNCT05290220 HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinomaunknown60
2023-12-15P3Vertex Pharmaceuticals Incorporated VERXNCT05553366 Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a BunionectomyAcute Paincompleted1075
2023-12-15 est.P2Samus Therapeutics, Inc.NCT05612633 A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPNAccelerated Phase MPN; Blast Phase MPNwithdrawn
2023-12-15P2Chong Kun Dang PharmaceuticalNCT05677438 A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic AlopeciaAndrogenetic Alopeciacompleted121
2023-12-15P2Okyo Pharma Ltd OKYONCT05759208 The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseaseDry Eye Diseasecompleted240
2023-12-15P2MiMedx Group, Inc. MDXGNCT05796765 Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee OsteoarthritisKnee Osteoarthritisterminated43
2023-12-16 est.P2PhagenixNCT05369104 Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.Infection of Total Hip Joint Prosthesis; Infection of Total Knee Joint Prosthesisunknown64
2023-12-17 est.P1/P2Bristol-Myers Squibb BMYNCT04151563 A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and ChCarcinoma, Non-small Cell Lung Cancerwithdrawn
2023-12-17P1/P2Triumvira Immunologics, Inc.NCT04727151 TAC T-cells for the Treatment of HER2-positive Solid TumorsHER2 Positive Gastric Cancer; Metastatic HER2 Positive Gastroesophageal Junction Cancerterminated28
2023-12-17P3Shanghai Henlius BiotechNCT05352516 A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of FracturePostmenopausalcompleted514
2023-12-18P2Merck Sharp & Dohme LLC MRKNCT04218851 Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)Invasive Aspergillosiscompleted31
2023-12-18P2Vivoryon Therapeutics N.V.NCT04498650 A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild ADEarly Alzheimers Disease; Mild Cognitive Impairment Due to ADcompleted259
2023-12-18P2Lipocine Inc. LPCNNCT04874350 A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaLiver Cirrhosis; Sarcopeniacompleted30
2023-12-18P3Novartis Pharmaceuticals NVSNCT05032157 A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistaminesChronic Spontaneous Urticariacompleted455
2023-12-18P2Allakos Inc.NCT05155085 A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic DermatitisAtopic Dermatitisterminated131
2023-12-18P2TrueBinding, Inc.NCT05156827 A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic StrokeAcute Ischemic Strokewithdrawn
2023-12-18P2SensorionNCT05258773 Evaluation of the Presence of SENS-401 in the PerilymphHearing Losscompleted28
2023-12-18P3Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT05881785 Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial SpondyloarthritisAxial Spondyloarthritiscompleted465
2023-12-19P1/P2Amytrx Therapeutics, Inc.NCT04313400 Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic DermatitisAtopic Dermatitiscompleted91
2023-12-19P2CelgeneNCT04350463 A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced CancersNeoplasmscompleted92
2023-12-19P1/P2Takeda TAKNCT04501614 A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL); Ph+ Mixed Phenotypterminated11
2023-12-19P1/P2Allist Pharmaceuticals, Inc.NCT04720976 JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid TumorsSolid Tumor; NSCLCcompleted58
2023-12-19P2Pierre Fabre MedicamentNCT05004350 A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOBRAF V600E; Metastatic Colorectal Cancercompleted107
2023-12-19P1/P2Arcturus Therapeutics, Inc. ARCTNCT05037097 A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy AdultsCOVID-19; SARS-CoV-2 Infection; Corona Virus Infectioncompleted72
2023-12-19P2Gilead Sciences GILDNCT05052996 Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIVHIV-1 Infectionactive not recruiting142
2023-12-19P1/P2LG ChemNCT05237752 A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OAOsteoarthritis, Kneecompleted74
2023-12-19P2Incyte Corporation INCYNCT05247489 A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With VitiligoVitiligocompleted55
2023-12-19P2ModernaTX, Inc.NCT05868382 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy AdultsInfluenzacompleted270
2023-12-19P2Iacta PharmaceuticalsNCT05992922 A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult ParticipantsDry Eye Syndromesterminated40
2023-12-20P2CelgeneNCT03361748 Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple MyelomaMultiple Myelomacompleted149
2023-12-20P3Advicenne PharmaNCT03644706 Study Evaluating Subjects With Distal Renal Tubular AcidosisDistal Renal Tubular Acidosisterminated3
2023-12-20P1/P2Teva Branded Pharmaceutical Products R&D LLCNCT04157517 A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsNeoplasms; Melanomaterminated45
2023-12-20P3CellSeed Inc.NCT04689594 A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial EsSuperficial Esophageal Cancerterminated1
2023-12-20P3BeiGeneNCT04921358 Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNon-Small Cell Lung Cancer (NSCLC)terminated377
2023-12-20P3InDex PharmaceuticalsNCT04985968 The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative ColitisUlcerative Colitisterminated171
2023-12-20P2CuraSen Therapeutics, Inc.NCT05104463 A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's DiseaseMild Cognitive Impairment; Dementiacompleted64
2023-12-20P2Jazz Pharmaceuticals JAZZNCT05126433 Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumor; Metastatic Solid Tumor; Urothelial Cancer; Poorly Differentiated Neuroendocrinterminated47
2023-12-20 est.P2Shanghai Henlius BiotechNCT05246982 HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric CancerGastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)unknown40
2023-12-20 est.P1/P2Shanghai Mabgeek Biotech.Co.LtdNCT05382910 A Study of MG-K10 in Subjects With AsthmaAsthmaunknown180
2023-12-20P2Merck Sharp & Dohme LLC MRKNCT05446870 Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)High-grade Serous Ovarian Carcinoma; Ovarian Carcinomacompleted160
2023-12-20P2/P3Innovent Biologics (Suzhou) Co. Ltd.NCT05795621 A Study of IBI311 in Subjects With Active Thyroid Eye DiseaseThyroid Eye Diseasecompleted115
2023-12-20P2Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT06439433 ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV InfectionCervical Intraepithelial Neoplasia Grade 2; Papillomavirus Infections; p16 Proteincompleted119
2023-12-20P3Jecho Biopharmaceuticals Co., Ltd.NCT07389577 A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degenerationcompleted443
2023-12-21P3Coherex MedicalNCT03302494 WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2Stroketerminated248
2023-12-21P2Eisai Inc.NCT03477175 Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Solid Tumorscompleted40
2023-12-21P3ActelionNCT04271475 A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary HypertensionChronic Thromboembolic Pulmonary Hypertensionterminated127
2023-12-21P3Ocular Therapeutix, Inc. OCULNCT04539548 A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric CataractCataractcompleted65
2023-12-21P2Jazz Pharmaceuticals JAZZNCT04745026 Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum DisorderAutism Spectrum Disordercompleted103
2023-12-21P1/P2Guangdong Raynovent Biotech Co., LtdNCT05119972 Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis (IPF)completed15
2023-12-21 est.P2Shandong Suncadia Medicine Co., Ltd.NCT05759897 A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes MellitusType 2 Diabetesunknown180
2023-12-22P2SecuraBioNCT03372057 A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Peripheral T-cell Lymphomacompleted156
2023-12-22P3AvadelNCT04451668 An Open Label Study of FT218 in Subjects With NarcolepsyNarcolepsy; Cataplexy; Excessive Daytime Somnolence; Sleep Disorder; Sleep Disturbance; Sleep Wake Dcompleted184
2023-12-22P2Taiho Pharmaceutical Co., Ltd.NCT05335499 A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous UrticariaChronic Spontaneous Urticariacompleted126
2023-12-23P3Beijing Northland Biotech. Co., Ltd.NCT04274049 Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)Arterial Occlusive Disease; Ischemia; Ulcers; Peripheral Vascular Diseasecompleted242
2023-12-23P2GoloNCT05844631 The Effects of the GOLO for Life® Plan and Release Supplement on Weight Management in Overweight and Obese AdultsObese; Overweightcompleted83
2023-12-24P3TenNor Therapeutics (Suzhou) LimitedNCT05857163 Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori InfectionH.Pylori Infectioncompleted700
2023-12-25P3Astellas Pharma IncNCT03182244 A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) MutatAML With FLT3 Mutationcompleted276
2023-12-25P3APRINOIA TherapeuticsNCT05542953 [18F]APN-1607 PET in Subjects With AD Compared to HCAlzheimer's Disease; Mild Cognitive Impairment Due to Alzheimer's Disease; Healthy Volunteerscompleted230
2023-12-25P1/P2BioNova Pharmaceuticals (Shanghai) LTD.NCT05611853 Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell MalignanciesB-cell Lymphoma; Non Hodgkin Lymphoma; Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Mantle Ceterminated9
2023-12-25P3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06091436 To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as ReferenceInfertilitycompleted176
2023-12-26P2CStone PharmaceuticalsNCT05297890 A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung CancerAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung Canceractive not recruiting70
2023-12-26P1/P2Suzhou Junjing BioSciences Co., Ltd.NCT05326035 A Study of WJ05129 in Advanced Malignant Solid TumorsLocally Advanced or Metastatic Malignant Solid Tumorsterminated26
2023-12-26P3Shanghai Pharmaceuticals Holding Co., LtdNCT05359068 Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential HypertensionEssential Hypertensioncompleted957
2023-12-26P2Taisho Pharmaceutical Co., Ltd.NCT05699239 A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on HemodialysisHyperphosphatemia Patients on Hemodialysiscompleted326
2023-12-27P3ActelionNCT03422328 A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan Pulmonary Arterial Hypertension; Chronic Thromboembolic Pulmonary Hypertensioncompleted151
2023-12-27P2Beijing InnoCare Pharma Tech Co., Ltd.NCT03797456 A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)MZLcompleted111
2023-12-27P1/P2Laekna LimitedNCT04060394 Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPCMetastatic Castration-resistant Prostate Cancercompleted49
2023-12-27P3Novartis Pharmaceuticals NVSNCT05030311 A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 AntihistaminesChronic Spontaneous Urticariacompleted470
2023-12-27P3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05051761 Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia AreataAlopecia Areatacompleted425
2023-12-27P2Allakos Inc.NCT05528861 A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous UrticariaChronic Spontaneous Urticariaterminated127
2023-12-27P2Pliant Therapeutics, Inc. PLRXNCT05621252 Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)Idiopathic Pulmonary Fibrosiscompleted10
2023-12-28P1/P2Forma Therapeutics, Inc.NCT02719574 Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 MutationAcute Myeloid Leukemia; Acute Myelogenous Leukemia; Myelodysplastic Syndromecompleted336
2023-12-28P2/P3Novartis Pharmaceuticals NVSNCT03217422 ADCC Mediated B-Cell dEpletion and BAFF-R BlockadeAutoimmune Hepatitiscompleted68
2023-12-28P3Baxalta now part of ShireNCT03393975 A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)Thrombotic Thrombocytopenic Purpura (TTP)completed52
2023-12-28P1/P2ImmunoGen, Inc.NCT04622774 First-in-Human Study of IMGC936 in Participants With Advanced Solid TumorsAdvanced Solid Tumorcompleted56
2023-12-28P3Takeda TAKNCT04668157 A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood PressureHypertensioncompleted10
2023-12-28P2/P3HilleVaxNCT05281094 Efficacy and Safety of Two Doses of HIL-214 in ChildrenGastroenteritisterminated3084
2023-12-28P2Modern Biosciences Ltd MDRNNCT05460832 Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RARheumatoid Arthritiscompleted248
2023-12-28P2/P3Yisheng Biopharma (Singapore) Pte. Ltd.NCT05463419 A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.Covid-19 Vaccinecompleted5860
2023-12-28P2BioNTech SE BNTXNCT05596734 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and InfluenzaInfluenza, Human; COVID-19completed1019
2023-12-28P2Clinuvel Pharmaceuticals Limited CUVLNCT05854784 Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)Variegate Porphyriacompleted6
2023-12-29P2/P3Serum Institute of India Pvt. Ltd.NCT03152903 Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB RecurrencePrevention of TB Recurrencecompleted2000
2023-12-29P1/P2GeoVax, Inc. GOVXNCT03754933 Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck CancerRecurrent Head and Neck Cancercompleted10
2023-12-29P3Novartis Pharmaceuticals NVSNCT03785405 Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HFHeart Failurecompleted216
2023-12-29P1/P2Jacobio Pharmaceuticals Co., Ltd.NCT04721223 JAB-3068 Activity in Adult Patients With Advanced Solid TumorsAdvanced Solid Tumor; Esophageal Squamous Cell Carcinoma; Non Small Cell Lung Cancer; Head and Neck completed12
2023-12-29P2Eli Lilly and Company LLYNCT05123586 A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus ErythematosusSystemic Lupus Erythematosusterminated85
2023-12-29P3Angiocrine BioscienceNCT05181540 A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell TransplantationHodgkin Lymphoma; Non Hodgkin Lymphomaterminated130
2023-12-29P2OcuTerra Therapeutics, Inc.NCT05409235 Nesvategrast (OTT166) in Diabetic Retinopathy (DR)Diabetic Retinopathycompleted225
2023-12-29 est.P2Inreda Diabetic B.V.NCT05454709 A Stable Glucagon Analog Administered by a Bihormonal Closed Loop SystemDiabetes Mellitus, Type 1withdrawn
2023-12-30P1/P2Golden Biotechnology CorporationNCT03310632 Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic CancerPancreatic Neoplasmcompleted55
2023-12-30 est.P3Shanghai Henlius BiotechNCT04033354 A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (CarboplatinSquamous Non Small Cell Lung Cancerunknown537
2023-12-30 est.P2MedPacto, Inc.NCT04064190 Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint InhibitionUrothelial Carcinoma Recurrent; Advanced Urothelial Carcinomawithdrawn
2023-12-30 est.P2ImmuniMed Inc.NCT04121169 Treatment of Mild-moderate Clostridium Difficile Infection (CDI)Clostridium Difficile Infection (CDI)unknown60
2023-12-30P2AgelessRxNCT04488601 Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity StudyAgingcompleted129
2023-12-30 est.P3Hamad Medical CorporationNCT04571879 Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in ChildrenProcedural Anxiety; Procedural Painunknown48
2023-12-30P3Mirati Therapeutics Inc.NCT04685135 Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C MutationMetastatic Non Small Cell Lung Cancer; Advanced Non Small Cell Lung Canceractive not recruiting453
2023-12-30P3Checkpoint Therapeutics, Inc.NCT04786964 Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLCMetastatic Non-squamous Non Small Cell Lung Cancerterminated25
2023-12-30 est.P2Reponex Pharmaceuticals A/SNCT04823962 Effect of rhGM-CSF on the Healing of Venous Leg UlcersVenous Leg Ulcerunknown6
2023-12-30 est.P2PharmaTher Inc.NCT04912115 Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced DyskinesiaDyskinesias; Movement Disorders; Central Nervous System Diseases; Nervous System Diseases; Neurologisuspended30
2023-12-30P1/P2WPD Pharmaceuticals Sp. z o.o.NCT04915404 Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)Recurrent Glioblastoma Multiformeterminated5
2023-12-30 est.P1/P2SkinJect, Inc.NCT04928222 Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)Basal Cell Carcinomaactive not recruiting25
2023-12-30P1/P2Oticara Australia PTY LTDNCT05220293 Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal CreamChronic Rhinosinusitis (Diagnosis)terminated2
2023-12-30 est.P2Beijing InnoCare Pharma Tech Co., Ltd.NCT05232149 A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune ThrombocytopeniaPrimary Immune Thrombocytopeniaunknown30
2023-12-30 est.P2Blade TherapeuticsNCT05373914 RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosisunknown200
2023-12-30 est.P1/P2Maxinovel Pty., Ltd.NCT05425602 A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid TumorsAdvanced / Metastatic Solid Tumorsunknown108
2023-12-30P2BioMimetix JV, LLCNCT05491447 A Clinical Trial of BMX-010 in Adult Subjects With Atopic DermatitisAtopic Dermatitisterminated103
2023-12-30 est.P2Shijiazhuang Yiling Pharmaceutical Co. LtdNCT05515393 A Study of XY03-EA Tablets in the Treatment of Acute Ischemic StrokeAcute Ischemic Strokeunknown420
2023-12-30P1/P2Chongqing Precision Biotech Co., LtdNCT05538195 Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid TumorsGastric Cancer; Colon Cancer; Rectal Cancer; Esophageal Cancer; Pancreatic Cancercompleted17
2023-12-30 est.P1/P2Qilu Pharmaceutical Co., Ltd.NCT05603039 A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular CarcinomaAdvanced Liver Cancerunknown80
2023-12-30 est.P2Keymed Biosciences Co.LtdNCT05671432 The Study of CM326 in Moderate-to-severe Atopic DermatitisModerate-to-severe Atopic Dermatitisunknown240
2023-12-30P3BRIM Biotechnology Inc.NCT05695781 Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.Dry Eye Diseasecompleted740
2023-12-30 est.P1/P2Suzhou Puhe Pharmaceutical Technology Co., LTDNCT05767866 Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFRTreatment; Treatment Side Effectsunknown160
2023-12-30P2CureLab OncologyNCT05979298 Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian CancerOvarian Cancer; Platinum-resistant Ovarian Cancercompleted40
2023-12-30P3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07028320 To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture RiskPostmenopausal Women With Osteoporosiscompleted493
2023-12-31 est.P1/P2Nanjing Legend Biotech Co.NCT03090659 LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple MyelomaRefractory or Relapsed Multiple Myelomaunknown100
2023-12-31 est.P1/P2NeuroGenerationNCT03309514 Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's DiseaseParkinson's Diseasewithdrawn
2023-12-31P1/P2Agalimmune Ltd.NCT03593226 Study to Evaluate Safety & Tolerability of AGI-134 in Solid TumourSuperficial, Palpable, Unresectable/Metastatic Solid Tumourcompleted38
2023-12-31P1/P2BioMimetix JV, LLCNCT03608020 A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain RadiotherapyMultiple Brain Metastasesterminated35
2023-12-31 est.P2/P3Kartos Therapeutics, Inc.NCT03662126 KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor TreatmentPrimary Myelofibrosis (PMF); Post-Polycythemia Vera MF (Post-PV-MF); Post-Essential Thrombocythemia unknown385
2023-12-31P2Igy Inc.NCT03707730 A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac DiseaseCeliac Diseasecompleted161
2023-12-31 est.P2ImmunoVaccine Technologies, Inc. (IMV Inc.)NCT03836352 Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent SolidOvarian Cancer; Hepatocellular Carcinoma; Non-small Cell Lung Cancer; Bladder Cancer; Microsatelliteactive not recruiting184
2023-12-31 est.P2Beijing Biostar Pharmaceuticals Co., Ltd.NCT03906565 Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal CancerAdvanced or Metastatic CRCsuspended30
2023-12-31P1/P2Buzzard PharmaceuticalsNCT04121442 Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid TumorsSolid Tumor, Adultcompleted15
2023-12-31P2RevimmuneNCT04154826 Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung DiseaseMycobacterium Infections, Nontuberculousterminated8
2023-12-31 est.P3CerecinNCT04187547 A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label ExtensionAlzheimer's Diseasewithdrawn
2023-12-31 est.P2Vivacelle BioNCT04257136 VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock PatientsSeptic Shock; Sepsis; Hypovolemiaunknown20
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04265963 CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid LeukemiaLeukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acuteunknown45
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04271410 CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and LymphomaLeukemia; Lymphoma, Large B-Cell, Diffuse; Leukemia, B-cell; Lymphoma, B-Cell; Leukemia, Lymphocyticunknown80
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04271800 Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and LymphomaLeukemia; Lymphoma; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cellunknown40
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04272125 Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid LeukemiaLeukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acuteunknown40
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04272151 Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple MyelomaMultiple Myeloma; Multiple Myeloma in Relapse; Neoplasm, Plasma Cellunknown40
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04348643 Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerSolid Tumor; Lung Cancer; Colorectal Cancer; Liver Cancer; Pancreatic Cancer; Gastric Cancer; Breastwithdrawn
2023-12-31P2Alethia BiotherapeuticsNCT04364620 AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)NSCLC Stage IVcompleted35
2023-12-31 est.P2Beijing InnoCare Pharma Tech Co., Ltd.NCT04438044 A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSLPCNSL; Secondary Central Nervous System Lymphomaunknown61
2023-12-31 est.P2Sound Pharmaceuticals, Incorporated SOGPNCT04484025 SPI-1005 Treatment in Moderate COVID-19 PatientsCovid19; Corona Virus Infection; Coronavirus; Coronavirus Infectionenrolling by invitation60
2023-12-31 est.P2Minoryx Therapeutics, S.L.NCT04528706 A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease ProgressionCerebral Adrenoleukodystrophyunknown13
2023-12-31P3Merck Sharp & Dohme LLC MRKNCT04635423 Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)Warts, Genital; Neoplasms, Analcompleted1059
2023-12-31P1/P2AkesoNCT04647344 A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerLung Cancer Non-Small Cell Stage IIIB/IIIC/IVcompleted46
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04648475 Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and LymphomaLeukemia, B-cell; Lymphoma, B-Cellunknown40
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04649983 CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and LymphomaLeukemia, B-cell; Lymphoma, B-Cellunknown40
2023-12-31P2Galecto Biotech ABNCT04679870 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With MyelofibrosisMyelofibrosisactive not recruiting21
2023-12-31 est.P1/P2Chongqing Precision Biotech Co., LtdNCT04782193 a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell LymphomaB Cell Lymphomaunknown40
2023-12-31P1/P2Genfleet Therapeutics (Shanghai) Inc.NCT04914286 A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid TumorsAdvanced Solid Tumorcompleted148
2023-12-31P1/P2CicloMed LLCNCT04956042 Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemiaterminated18
2023-12-31 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT05042375 A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung CancerNon-small Cell Lung Cancerunknown450
2023-12-31 est.P2Shandong New Time Pharmaceutical Co., LTDNCT05178836 A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCLRR DLBCL; PD-1; CD20unknown62
2023-12-31 est.P1/P2Mindful Diagnostics and Therapeutics, LLCNCT05183516 Tdap and Biomarkers of Alzheimer's DiseaseAlzheimer Disease, Late Onsetunknown50
2023-12-31 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT05193214 A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic SarcomaSarcoma, Soft Tissueunknown30
2023-12-31 est.P2ES Therapeutics Australia Pty LtdNCT05234762 Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential TremorsTremor, Essentialunknown24
2023-12-31P3KalVista Pharmaceuticals, Ltd.NCT05259917 A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult PHereditary Angioedemacompleted136
2023-12-31 est.P2Shanghai JMT-Bio Inc.NCT05278338 Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With OsteoporosisPostmenopausal Osteoporosisunknown200
2023-12-31P3Vaxine Pty LtdNCT05279456 A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)COVID-19completed39
2023-12-31 est.P2United BioPharma UTHRNCT05298215 A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic SpontaneousChronic Spontaneous Urticariaunknown25
2023-12-31 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05334810 DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast CancerHER2-positive Breast Cancerunknown191
2023-12-31P2TJ Biopharma Co., Ltd.NCT05338580 Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid TumorsFirst-line Non-small-cell Lung Cancer; First-line Urothelial Carcinoma; Second-line Urothelial Carciwithdrawn
2023-12-31 est.P2Beijing InnoCare Pharma Tech Co., Ltd.NCT05372120 A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene AlterationsAdvanced Solid Tumorunknown200
2023-12-31P2Genfleet Therapeutics (Shanghai) Inc.NCT05386888 A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLCNSCLC, Stage IIIcompleted65
2023-12-31 est.P3Betta Pharmaceuticals Co., Ltd.NCT05433480 A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast CancerBreast Cancerunknown274
2023-12-31 est.P1/P2Theratocular Biotek Co.NCT05456724 A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular HypertensionOpen Angle Glaucoma; Ocular Hypertensionunknown50
2023-12-31 est.P2DermBiont, Inc.NCT05493488 A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea PedisTinea Pedisunknown24
2023-12-31 est.P2/P3Genencell Co. Ltd.NCT05525182 Efficacy and Safety of ES16001 in Patients With COVID-19COVID-19unknown706
2023-12-31 est.P2TruDiagnosticNCT05535608 Targeting the Nine Hallmarks of Aging on DNA MethylationAgingunknown50
2023-12-31P3Vaxine Pty LtdNCT05542862 Booster Study of SpikoGen COVID-19 VaccineCOVID-19completed81
2023-12-31P3PT Bio FarmaNCT05546502 Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy ChildrenVaccine Reaction; Vaccine Adverse Reactioncompleted1050
2023-12-31P2Shanghai Henlius BiotechNCT05584137 Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRCColorectal Cancer Metastaticterminated2
2023-12-31 est.P2Zhejiang Genfleet Therapeutics Co., Ltd.NCT05618691 A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)Intermittent Claudication; Peripheral Artery Diseasewithdrawn
2023-12-31 est.P1/P2Innovent Biologics (Suzhou) Co. Ltd.NCT05653180 IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract CancerAdvanced Biliary Tract Cancerunknown20
2023-12-31 est.P2Attgeno ABNCT05699486 A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass SurgeryPulmonary Hypertensionunknown12
2023-12-31 est.P1/P2Vac4AllNCT05776017 MSP3-CRM-Vac4All/ Alhydrogel® VaccineMalaria,Falciparumunknown465
2023-12-31P2ZetrOZ, Inc.NCT05882812 Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to OsteoarthritisOsteo Arthritis Knee; Arthritiscompleted200
2023-12-31P2Immuno Cure 3 LimitedNCT05904054 Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)COVID-19completed31
2023-12-31 est.P3BiocadNCT05986331 Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced MelanomaMelanoma (Skin)unknown366
2023-12-31 est.P2Simon Williamson ClinicNCT06065722 Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic ChemotherapyChemotherapy Induced Nausea and Vomitingunknown100
2023-12-31P3NPO PetrovaxNCT06383819 Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19Post-Acute COVID-19 Syndrome; Lung Disease With Polymyositis; Fibrosis; Lung Diseases, Interstitial;completed392

← 2023-11 | 2024-01 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.